You are here

  • Home
  • Archive
  • Volume 4, Issue 7
  • Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial

Article metrics

Article menu
XML
Health economics
Research
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial

 

Online download statistics by month:

Online download statistics by month: July 2014 to June 2022

AbstractFullPdf
Jul 20141631116
Aug 2014103158109
Sep 20143812040
Oct 20146815243
Nov 20147214240
Dec 20143322732
Jan 20156523734
Feb 20158225960
Mar 201510924156
Apr 201512123749
May 20157628647
Jun 20157216736
Jul 20158714331
Aug 20156612138
Sep 20159014319
Oct 20155112227
Nov 20156111521
Dec 20157914334
Jan 20167712529
Feb 20167512022
Mar 2016729225
Apr 20169311727
May 2016297611
Jun 2016365012
Jul 2016529132
Aug 2016597642
Sep 2016575446
Oct 2016266741
Nov 2016206038
Dec 2016166211
Jan 2017154714
Feb 20179820
Mar 2017154117
Apr 201759822
May 2017125614
Jun 201719549
Jul 2017564814
Aug 2017736819
Sep 2017564311
Oct 2017714311
Nov 2017826212
Dec 2017564211
Jan 2018674510
Feb 2018605115
Mar 201812110119
Apr 201822721714
May 201810910213
Jun 20181049418
Jul 2018826812
Aug 2018696014
Sep 2018605417
Oct 201815313722
Nov 201812111515
Dec 201811510515
Jan 201911210019
Feb 2019686018
Mar 2019787124
Apr 2019575121
May 2019504138
Jun 2019686421
Jul 2019635216
Aug 2019594819
Sep 201927278
Oct 201955478
Nov 2019534717
Dec 2019393811
Jan 2020342910
Feb 2020523712
Mar 202035336
Apr 2020383428
May 2020342819
Jun 2020444024
Jul 2020464215
Aug 2020393516
Sep 2020868114
Oct 202013612611
Nov 202046396
Dec 2020524213
Jan 2021553914
Feb 2021292110
Mar 2021493720
Apr 2021523713
May 202141378
Jun 2021191912
Jul 202116166
Aug 2021171614
Sep 2021373616
Oct 2021353124
Nov 2021483929
Dec 2021403314
Jan 202255458
Feb 202248378
Mar 2022645816
Apr 2022434317
May 2022716033
Jun 2022502713
Total594576162095